Latent TGF-beta 1

Latent TGF-beta 1 詳細

英語名Transforming growth factor beta 1市販薬剤の数1
治験薬の数22ターゲットの別称Latency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
研究&開発段階Approved
英語名Transforming growth factor beta 1
ターゲットの別称Latency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
市販薬剤の数1
治験薬の数22
研究&開発段階Approved

Latent TGF-beta 1 製品リスト

  • 属性

    Protein (4)

  • 製品ライブラリ

    オンライン (4)

  • Human (2)Cynomolgus (1)Mouse (1)

  • タグ

    His Tag (3)His Tag & Avi Tag (1)

  • マーカー

    Unconjugated (3)Biotin-labeled (1)

Latent TGF-beta 1バックグランド

Transforming growth factor beta 1 ( TGFB1) is also known as TGF-β1, CED, DPD1, TGFB. is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis. The TGFB1 protein helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement (motility), and the self-destruction of cells (apoptosis). The TGFB1 protein is found throughout the body and plays a role in development before birth, the formation of blood vessels, the regulation of muscle tissue and body fat development, wound healing, and immune system function. TGFB1 is particularly abundant in tissues that make up the skeleton, where it helps regulate bone growth, and in the intricate lattice that forms in the spaces between cells (the extracellular matrix). Within cells, this protein is turned off (inactive) until it receives a chemical signal to become active. TGFB1 plays an important role in controlling the immune system, and shows different activities on different types of cell, or cells at different developmental stages. Most immune cells (or leukocytes) secrete TGFB1. TGFB1 has been shown to interact with TGF beta receptor 1, LTBP1, YWHAE, EIF3I and Decorin.

Latent TGF-beta 1分子の別称

Latent TGF-beta 1,Latent TGFB1,TGFB1,CED,DPD1,LAP,TGF-beta-1,TGFB

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
VactosertibTEW-7197; EW-7197; NOV-1301Phase 3 ClinicalMedpacto IncAdenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Solid tumours; Stomach Neoplasms; Urologic Neoplasms
詳細
Bintrafusp alfaM-7824; GSK-4045154; MSB-0011359CPhase 3 ClinicalMerck SeronoAnus Neoplasms; Biliary Tract Neoplasms; Brain metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Esthesioneuroblastoma, Olfactory; Gallbladder Neoplasms; Ganglioglioma; Head and Neck Neoplasms; Hematologic Neoplasms; Intestinal Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Microsatellite Instability; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Germ Cell and Embryonal; Nose Neoplasms; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Penile Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Respiratory papillomatosis; Sarcoma; Sarcoma, Kaposi; Skin Melanoma; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thymic epithelial tumor; Thymoma; Thymus Neoplasms; Triple Negative Breast Neop
詳細
NisevokitugNIS-793Phase 3 ClinicalXoma CorpAdenocarcinoma; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
詳細
Yinfenidone HydrochlorideHEC-585; HEC-00000585Phase 3 ClinicalHec Pharm Co LtdIdiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis
詳細
SB-01 (Ensol BioSciences)Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2KPhase 3 ClinicalEnsol Biosciences IncIntervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain
詳細
LivmoniplimabMGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115Phase 3 ClinicalArgenx SeCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Solid tumours
詳細
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncCarcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
ZSP-1603ZSP-1603Phase 2 ClinicalGuangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Neoplasms; Ovarian Neoplasms; Solid tumours; Thyroid Neoplasms
詳細
NicousamideXLF-III-43Phase 2 ClinicalInstitue Of Materia Medica Chinese Academy Of Medical ScienceDiabetic Nephropathies; Hypertensive nephropathy
詳細
Meflonidone hydrochloridePhase 2 ClinicalCentral South University, Guangzhou Nanxin Pharma Co LtdDiabetes Mellitus, Type 2; Diabetic Nephropathies
詳細
FluorofenidoneAKF-PDPhase 2 ClinicalCentral South University, Dierepharma HK Ltd, Hainan Haiyao Co LtdHepatitis B, Chronic; Liver Cirrhosis
詳細
CotsiranibSTP-705LU; STP-705LV; STP-705; STP-705LPhase 2 ClinicalSirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co LtdCarcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cicatrix, Hypertrophic; Keloid; Liver Neoplasms; Obesity, Abdominal
詳細
YL-13027YL-13027Phase 2 ClinicalYL-PharmaPancreatic Neoplasms; Solid tumours
詳細
MR-001MR001; MR-001Phase 2 ClinicalShenzhen Maijiarui Biotechnology Co LtdCarcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
LinavonkibartSRK-181; SRT-BETA-1-AB3Phase 1 ClinicalScholar Rock IncNeoplasms
詳細
Charis-1000Charis-1000; C 1K; C1KPhase 1 ClinicalEnsol Biosciences IncBreast Neoplasms
詳細
HLX-6018HLX-6018; HLX6018Phase 1 ClinicalIdiopathic Pulmonary Fibrosis
詳細
RO7496353RO7496353; RO-7496353; SOF 10; RG6440; RG-6440Phase 1 ClinicalGenentech IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours; Stomach Neoplasms
詳細
JYB-1907JYB-1907Phase 1 ClinicalJiangxi Jemincare Group Co LtdSolid tumours
詳細
STP-707STP-707; STP707Phase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co LtdCholangitis, Sclerosing; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms; Pulmonary Fibrosis; Solid tumours
詳細
PXS-64PXS-64Phase 1 ClinicalSyntara LtdMultiple Sclerosis
詳細
BMS-986416BMS-986416; AVID-200 DP; AVID-200Phase 1 ClinicalFormation Biologics CorpPolycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Tonogenchoncel-LTG-CApprovedTissuegeneInvossa-K, InvossaSouth KoreaOsteoarthritisnull2017-07-01Intervertebral Disc Degeneration; Osteoarthritis; Osteoarthritis, Knee
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8